Free Float -
Shares Float -
Shares Outstanding 80,05 M
RLS Global AB (publ)
Share · SE0005190725 (XSTO)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of RLS Global AB (publ)
No Price
Share Float & Liquidity
Company Profile for RLS Global AB (publ) Share
RLS Global AB (publ), a medical technology company, develops and sells products for the treatment of illnesses in wound and oral care in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. The company was founded in 1996 and is based in Mölndal, Sweden.
Company Data
Name RLS Global AB (publ)
Company RLS Global AB (publ)
Website
https://rls.global
Primary Exchange 
NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
ISIN SE0005190725
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Roland Frosing
Market Capitalization 36 Mio
Country Sweden
Currency SEK
Employees 0,0 T
Address Neongatan 5, 431 53 Mölndal
IPO Date 2005-07-11
Stock Splits
| Date | Split |
|---|---|
| 08.05.2013 | 1:10 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ STOCKHOLM AB | RLS.ST |
More Shares
Investors who hold RLS Global AB (publ) also have the following shares in their portfolio:
